Want to see MEDS full AI Analyst Report?
Total Valuation
DataMeds AI has a market cap or net worth of $4.21M. The enterprise value is $38.16M.
Market Cap$4.21M
Enterprise Value$38.16M
Share Statistics
DataMeds AI has 2,847,198 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,847,198
Owned by Insiders18.97%
Owned by Institutions―
Financial Efficiency
DataMeds AI’s return on equity (ROE) is 8.14 and return on invested capital (ROIC) is -659.05%.
Return on Equity (ROE)8.14
Return on Assets (ROA)-3.32
Return on Invested Capital (ROIC)-659.05%
Return on Capital Employed (ROCE)-119.52
Revenue Per Employee752.83K
Profits Per Employee-3.27M
Employee Count31
Asset Turnover0.77
Inventory Turnover20.11
Valuation Ratios
The current PE Ratio of DataMeds AI is ―. DataMeds AI’s PEG ratio is -0.00028.
PE Ratio―
PS Ratio1.22
PB Ratio-2.28
Price to Fair Value-2.28
Price to FCF-2.61
Price to Operating Cash Flow-0.16
PEG Ratio-0.00028
Income Statement
In the last 12 months, DataMeds AI had revenue of 23.34M and earned -101.27M in profits. Earnings per share was -71.50.
Revenue23.34M
Gross Profit-9.64M
Operating Income-81.19M
Pretax Income-101.27M
Net Income-101.27M
EBITDA-93.48M
Earnings Per Share (EPS)-71.50
Cash Flow
In the last 12 months, operating cash flow was -12.92M and capital expenditures -187.35K, giving a free cash flow of -13.11M billion.
Operating Cash Flow-12.92M
Free Cash Flow-13.11M
Free Cash Flow per Share-4.60
Dividends & Yields
DataMeds AI pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change-95.23%
50-Day Moving Average0.64
200-Day Moving Average―
Relative Strength Index (RSI)47.10
Average Volume (3m)28.82M
Important Dates
DataMeds AI upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
DataMeds AI as a current ratio of 0.09, with Debt / Equity ratio of -191.96%
Current Ratio0.09
Quick Ratio0.04
Debt to Market Cap0.85
Net Debt to EBITDA-0.26
Interest Coverage Ratio-17.73
Taxes
In the past 12 months, DataMeds AI has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
DataMeds AI EV to EBITDA ratio is -0.57, with an EV/FCF ratio of -4.89.
EV to Sales2.27
EV to EBITDA-0.57
EV to Free Cash Flow-4.89
EV to Operating Cash Flow-4.89
Balance Sheet
DataMeds AI has $51.73K in cash and marketable securities with $28.91M in debt, giving a net cash position of -$28.86M billion.
Cash & Marketable Securities$51.73K
Total Debt$28.91M
Net Cash-$28.86M
Net Cash Per Share-$10.14
Tangible Book Value Per Share-$26.03
Margins
Gross margin is -69.22%, with operating margin of -347.91%, and net profit margin of -433.95%.
Gross Margin-69.22%
Operating Margin-347.91%
Pretax Margin-433.95%
Net Profit Margin-433.95%
EBITDA Margin-400.57%
EBIT Margin-414.33%
Analyst Forecast
The average price target for DataMeds AI is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-51.59%
EPS Growth Forecast-25.99%